Skip to content
Stephanie Shulder

Stephanie Shulder

Contact

Call Center (585) 276-3000

About Me

Professional Background

Dr. Shulder is an Infectious Diseases clinical pharmacy specialist at the University of Rochester Medical Center. She serves as the co-chair for the Antimicrobial Stewardship subcommittee at URMC and serves as a member of the Society of Infectious Diseases Pharmacists (SIDP).

Dr. Shulder ea...
Dr. Shulder is an Infectious Diseases clinical pharmacy specialist at the University of Rochester Medical Center. She serves as the co-chair for the Antimicrobial Stewardship subcommittee at URMC and serves as a member of the Society of Infectious Diseases Pharmacists (SIDP).

Dr. Shulder earned her doctorate of pharmacy degree from the University of Maryland School of Pharmacy. Upon graduation, she completed PGY1 and PGY2 infectious diseases residencies at the Johns Hopkins Hospital in Baltimore, Maryland.

Combining her prior experience as a clinical microbiologist with her ID training, her research interests include evaluation of diagnostic platforms, management of patients with multi-drug resistant organisms, and antimicrobial stewardship.

Credentials

Post-doctoral Training & Residency

PGY2 Infectious Diseases Specialty Residency
The Johns Hopkins Hospital
Baltimore, Maryland 2016 - 2017

PGY1 Pharmacy Practice Residency
The Johns Hopkins Hospital
Baltimore, Maryland 2015 - 2016

Education

Doctor of Pharmacy | University of Maryland School of Pharmacy. Pharmacy. 2015

Certificate | University of Maryland School of Medicine. Microbiology. 2008

Bachelor of Science | University of Miami. Biology. 2006

Awards

URMC Meliora Award for C. difficile Infection Prevention Task Force. 2018

Research

Dr. Shulder's research interests include management of patients with multi-drug resistant organisms and antimicrobial stewardship.

Publications

Journal Articles

Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections.

Donnelly D, Pillinger KE, Debnath A, DePasquale W, Munsiff S, Louie T, Jones CMC, Shulder S

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2024 March 11 Epub 03/11/2024.

Infectious Diseases Consultation Associated with Reduced Mortality in Gram-Negative Bacteremia.

Shulder S, Tamma PD, Fiawoo S, Dzintars K, Escobar D, Livorsi DJ, Malani AN, Palacio D, Spivak ES, Zimmerman M, Bork JT

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2023 July 4 Epub 07/04/2023.

Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals.

Ince D, Fiawoo S, Choudhury R, Cosgrove SE, Dobrzynski D, Gold H, Lee JH, Percival KM, Shulder S, Sony D, Spivak ES, Tamma PD, Nori P

Open forum infectious diseases.. 2023 July 10 (7):ofad265. Epub 05/22/2023.

Impact of Case-Specific Education and Face-to-Face Feedback to Prescribers and Nurses in the Management of Hospitalized Patients With a Positive Test.

Fabre V, Markou T, Sick-Samuels A, Rock C, Avdic E, Shulder S, Dzintars K, Saunders H, Andonian J, Cosgrove SE

Open forum infectious diseases.. 2018 October 5 (10):ofy226. Epub 09/10/2018.

Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia.

Avdic E, Wang R, Li DX, Tamma PD, Shulder SE, Carroll KC, Cosgrove SE

The Journal of antimicrobial chemotherapy.. 2017 November 172 (11):3191-3198. Epub 1900 01 01.

Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens.

Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC

Journal of clinical microbiology.. 2010 November 48 (11):4294-7. Epub 08/25/2010.